4//SEC Filing
Ferguson James J. III 4
Accession 0001493152-21-000130
CIK 0001582554other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 6:30 PM ET
Size
5.6 KB
Accession
0001493152-21-000130
Insider Transaction Report
Form 4
Ferguson James J. III
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2021-01-01+575,000→ 575,000 totalExercise: $1.36Exp: 2030-12-31→ Common Stock (575,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2022 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2022.
Documents
Issuer
Matinas BioPharma Holdings, Inc.
CIK 0001582554
Entity typeother
Related Parties
1- filerCIK 0001769041
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 6:30 PM ET
- Size
- 5.6 KB